mRNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

TriLink BioTechnologies senior scientist Dr Cody Palumbo discusses the blockers to manufacturing mRNA-based gene editing ...

RNA, widely known from the COVID-19 vaccine, is not actually a “therapeutic agent,” but a technology that delivers the ...

Developers of mRNA therapeutics face an increasingly complex landscape: rising expectations for potency and durability, ...

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

Raina Biosciences published data from its generative AI platform in a study, “Deep generative models design mRNA sequences with enhanced translational capacity and stability,” recently published in ...

BIOVECTRA and Revolution Biomanufacturing partner to integrate mRNA sequence design with end-to-end GMP manufacturing for ...

C OVID-19 mRNA vaccines that saved millions of lives globally during the pandemic from 2021 onwards, have now been reported to help the body fight malignant cells, raising the prospect of a low-cost, ...